Voyager Therapeutics (VYGR) Interest Coverage Ratio (2014 - 2016)
Voyager Therapeutics' (VYGR) quarterly Interest Coverage Ratio came in at 33.99 in Q2 2016, down 38.32% year-over-year from 55.1 in Q3 2015, and up 26.99% quarter-over-quarter from 26.76 in Q1 2016.
Analysis
Voyager Therapeutics (VYGR) Interest Coverage Ratio (2014 - 2016) Analysis & Trends
Voyager Therapeutics has disclosed Interest Coverage Ratio across 3 years of filings, most recently posting 33.99 for Q2 2016.
- In Q2 2016, Interest Coverage Ratio fell 38.32% year-over-year to 33.99; the TTM figure through Jun 2016 stood at 42.99 (up 2692.42% YoY), while the FY2015 annual figure was 2.08, up 71.8% from the prior year.
- Interest Coverage Ratio came in at 33.99 for Q2 2016 at Voyager Therapeutics, up from 26.76 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 55.1 in Q2 2015 to a low of 23.18 in Q4 2014.
- Average Interest Coverage Ratio over 3 years is 17.3, with a median of 26.76 recorded in 2016.
- The largest YoY upside for Interest Coverage Ratio was 5504.24% in 2016 against a maximum downside of 38.32% in 2016.
- Over 3 years, Interest Coverage Ratio stood at 23.18 in 2014, then soared by 270.02% to 39.4 in 2015, then retreated by 13.75% to 33.99 in 2016.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 33.99 in Q2 2016, 26.76 in Q1 2016, and 39.4 in Q3 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | -0.01 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 9.95 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | -3.63 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 7.67 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 2.71 |
| 10 | Voyager Therapeutics | 195.27 Mn | 78.93 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2016 | 33.99 |
| Mar 31, 2016 | 26.76 |
| Sep 30, 2015 | 39.40 |
| Jun 30, 2015 | 55.10 |
| Mar 31, 2015 | -0.50 |
| Dec 31, 2014 | -23.18 |
| Sep 30, 2014 | -10.48 |